These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 9169752)
41. Protection of mice and swine against infection with Actinobacillus pleuropneumoniae by vaccination. Beaudet R; McSween G; Boulay G; Rousseau P; Bisaillon JG; Descoteaux JP; Ruppanner R Vet Microbiol; 1994 Mar; 39(1-2):71-81. PubMed ID: 8203129 [TBL] [Abstract][Full Text] [Related]
42. Construction and immunization with double mutant Δ Dao HT; Truong QL; Do VT; Hahn TW J Vet Sci; 2020 Mar; 21(2):e20. PubMed ID: 32233129 [No Abstract] [Full Text] [Related]
43. Protective local and systemic antibody responses of swine exposed to an aerosol of Actinobacillus pleuropneumoniae serotype 1. Bossé JT; Johnson RP; Nemec M; Rosendal S Infect Immun; 1992 Feb; 60(2):479-84. PubMed ID: 1730479 [TBL] [Abstract][Full Text] [Related]
44. [Cloning and expression of hemolytic-toxin from Actinobacillus pleuropneumoniae and the immunoprotection in mice]. Du A; Diao Y; Zhang W; Zhang R; Zang D; Liu F Wei Sheng Wu Xue Bao; 2008 Mar; 48(3):342-8. PubMed ID: 18479061 [TBL] [Abstract][Full Text] [Related]
45. Use of passive immunization for the production of monoclonal antibodies against Actinobacillus pleuropneumoniae serotype 1,6 and 12. Stenbaek E J Immunol Methods; 1992 Dec; 156(2):267-9. PubMed ID: 1474261 [TBL] [Abstract][Full Text] [Related]
46. An evaluation of the role of antibodies to Actinobacillus pleuropneumoniae serovar 1 and 15 in the protection provided by sub-unit and live streptomycin-dependent pleuropneumonia vaccines. Tumamao JQ; Bowles RE; van den Bosch H; Klaasen HL; Fenwick BW; Blackall PJ Aust Vet J; 2004 Dec; 82(12):773-80. PubMed ID: 15648941 [TBL] [Abstract][Full Text] [Related]
47. The induction of specific protection against Actinobacillus pleuropneumoniae infection by specific DLE. Snirc J; Mikula I; Pistl J Acta Microbiol Hung; 1993; 40(4):325-33. PubMed ID: 7976208 [TBL] [Abstract][Full Text] [Related]
48. Nasal immunization with M cell-targeting ligand-conjugated ApxIIA toxin fragment induces protective immunity against Actinobacillus pleuropneumoniae infection in a murine model. Park J; Seo KW; Kim SH; Lee HY; Kim B; Lim CW; Kim JH; Yoo HS; Jang YS Vet Microbiol; 2015 May; 177(1-2):142-53. PubMed ID: 25818577 [TBL] [Abstract][Full Text] [Related]
49. Genome-wide screening of lipoproteins in Actinobacillus pleuropneumoniae identifies three antigens that confer protection against virulent challenge. Cao Y; Gao L; Zhang L; Zhou L; Yang J; Deng L; Zhao J; Qi C; Liu J Sci Rep; 2020 Feb; 10(1):2343. PubMed ID: 32047221 [TBL] [Abstract][Full Text] [Related]
50. Interference of outer membrane protein PalA with protective immunity against Actinobacillus pleuropneumoniae infections in vaccinated pigs. van den Bosch H; Frey J Vaccine; 2003 Sep; 21(25-26):3601-7. PubMed ID: 12922088 [TBL] [Abstract][Full Text] [Related]
51. A novel strategy for protective Actinobacillus pleuropneumoniae subunit vaccines: detergent extraction of cultures induced by iron restriction. Goethe R; Gonzáles OF; Lindner T; Gerlach GF Vaccine; 2000 Nov; 19(7-8):966-75. PubMed ID: 11115723 [TBL] [Abstract][Full Text] [Related]
52. Development of Jung M; Won H; Shin MK; Oh MW; Shim S; Yoon I; Yoo HS J Vet Sci; 2019 Mar; 20(2):e2. PubMed ID: 30944525 [TBL] [Abstract][Full Text] [Related]
53. Galactose-1-phosphate uridyltransferase (GalT), an in vivo-induced antigen of Actinobacillus pleuropneumoniae serovar 5b strain L20, provided immunoprotection against serovar 1 strain MS71. Zhang F; Zhao Q; Quan K; Zhu Z; Yang Y; Wen X; Chang YF; Huang X; Wu R; Wen Y; Yan Q; Huang Y; Ma X; Han X; Cao S PLoS One; 2018; 13(6):e0198207. PubMed ID: 29856812 [TBL] [Abstract][Full Text] [Related]
54. Development of a DIVA subunit vaccine against Actinobacillus pleuropneumoniae infection. Maas A; Meens J; Baltes N; Hennig-Pauka I; Gerlach GF Vaccine; 2006 Nov; 24(49-50):7226-37. PubMed ID: 17027123 [TBL] [Abstract][Full Text] [Related]
55. [Study on immunogenicity of the N-terminal polypeptide of RTX toxin I of Actinobacillus pleuropneumoniae]. Mei L; Zhou R; Lu HS; Bei WC; Liu WH; Lin LW; Hong WZ; Chen HC Sheng Wu Gong Cheng Xue Bao; 2006 Jan; 22(1):39-45. PubMed ID: 16572838 [TBL] [Abstract][Full Text] [Related]
56. Positive role for rApxIVN in the immune protection of pigs against infection by Actinobacillus pleuropneumoniae. Wang C; Wang Y; Shao M; Si W; Liu H; Chang Y; Peng W; Kong X; Liu S Vaccine; 2009 Sep; 27(42):5816-21. PubMed ID: 19654060 [TBL] [Abstract][Full Text] [Related]
57. A trivalent Apx-fusion protein delivered by E. coli outer membrane vesicles induce protection against Actinobacillus pleuropneumoniae of serotype 1 and 7 challenge in a murine model. Xu K; Zhao Q; Wen X; Wu R; Wen Y; Huang X; Huang Y; Yan Q; Han X; Ma X; Chang YF; Cao S PLoS One; 2018; 13(1):e0191286. PubMed ID: 29373591 [TBL] [Abstract][Full Text] [Related]
58. Effect of endobronchial challenge with Actinobacillus pleuropneumoniae serotype 10 of pigs vaccinated with bacterins consisting of A. pleuropneumoniae serotype 10 grown under NAD-rich and NAD-restricted conditions. van Overbeke I; Chiers K; Donne E; Ducatelle R; Haesebrouck F J Vet Med B Infect Dis Vet Public Health; 2003 Aug; 50(6):289-93. PubMed ID: 14629000 [TBL] [Abstract][Full Text] [Related]
59. Immunogenicity and protective efficacy of ApxIA and ApxIIA DNA vaccine against Actinobacillus pleuropneumoniae lethal challenge in murine model. Chiang CH; Huang WF; Huang LP; Lin SF; Yang WJ Vaccine; 2009 Jul; 27(34):4565-70. PubMed ID: 19520199 [TBL] [Abstract][Full Text] [Related]
60. Characterization of monoclonal antibodies against Actinobacillus pleuropneumoniae serotype 5. Nakai T; Kawahara K; Horiguchi Y; Danbara H; Kume K Am J Vet Res; 1992 Sep; 53(9):1519-23. PubMed ID: 1384404 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]